Pro Health Tips
Friday, 1 December 2017
Positive Results Shown by Phase III Immunotherapy Trial for Migraine
An antibody therapy against a key inflammatory molecule involved in migraines reduces the number of headaches that chronic migraine patients experience per month.
from Medindia Health News http://ift.tt/2BrgyZ5
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
An antibody therapy against a key inflammatory molecule involved in migraines reduces the number of headaches that chronic migraine patients experience per month.
No comments:
Post a Comment